PSMA PET/CT appears to be a promising and superior staging investigation that may replace bone scan and CT scan in guiding treatment decision-making. It has high specificity and positive predictive value, thus in patients with low-risk prostate cancer, unnecessary extended pelvic lymph node dissecti...
PSMA PET scanPelvic lymph node dissectionRadical prostatectomyObjectives: Staging of extra-prostatic prostate cancer has traditionally been assessed by computerised tomography (CT), bone scan, and where indicated, pelvic lymph node dissection at the time of surgery. The advent of the prostate-specific ...
The purpose of this retrospective, multicenter study was to assess efficacy of PSMA-PET/CT-guided salvage radiotherapy (sRT) in patients with recurrent or
Alicia Morgans, MD, MPH: One thing that’s important is that we understand what a PSMA [prostate-specific membrane antigen] PET [positron emission tomography] scan does, how it works, and how it can be useful in our practice. Phil, can you go through a little bit of the nuts and ...
UPDATE: Now Performing PSMA PET SCANS - Schedule with us today, The #1 HIGHEST Rated PET scan service provider nationwide.
PSMA PET scan identifies cancer that is often missed by current standard-of-care imaging techniques. However, this scan is still not widely available and resource allocation may be a problem. Therefore, it is imperative to identify patients who are most likely to benefit from this novel...
68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report Recently, positron emission tomography (PET) imaging using PSMA-ligands has gained high attention as a promising new radiotracer in patients with prostate ... I Rauscher,T Maurer,WP Fendler,... - 《Cancer ...
For PET studies, each animal received 20-30 microg of radiolabeled mAb corresponding to an activity of 7.6-11.5 MBq. Imaging was performed 3, 24, and 48 h after injection. After the last scan, the mice were sacrificed and tracer in vivo biodistribution was measured by gamma-counting.Binding...
Twenty-one patients (65.6%) showed new metastases on post-treatment scan. In seven patients (21.9%) no suspicious lesion could be found on PSMA-PET/CT, despite of biochemical recurrence. The rest of the patients (12.5%) had progressive lesions only apparent in hindsight (n = 2) or ...
The increasing availability of PSMA PET/MR scanners is likely to pave the way for simultaneous integration of anatomic, functional and biologic information for men undergoing prostate cancer care[4]. In this article, we provide an overview of the clinical applications of 68 Ga-PSMA-11 PET-MR ...